of
adaptive
potential were assessed according to R.M. Baevsky.
It was revealed that such parameter as decrease
ОЦЕНКА ЧАСТОТЫ ГЛАЗНЫХ ИЗМЕНЕНИЙ И КАЧЕСТВА ЖИЗНИ ПАЦИЕНТОВ ПРИ ХРОНИЧЕСКИХ МИЕЛОПРОЛИФЕРАТИВНЫХ ЗАБОЛЕВАНИЯХYunusova, EM;,
Mukhamadeev, TR;,
Bakirov, BA,
Юнусова, Э. М.,
Мухамадеев, Т. Р.,
Бакиров, Б. А. (2022) опросника «National eye institute
visual
function questionnaire-25», обследованы стандартными и специальными
attention in this context. They emerge as pivotal biomarkers and
potential therapeutic targets, offering
Mingazheva, E.T.,
Prokofyeva, D.S.,
Valova, Ya.V.,
Andreeva, E.A.,
Nurgalieva, A.Kh.,
Valiev, R.R.,
Ekomasova, N.V.,
Faishanova, R.R.,
Romanova, A.R.,
Khusnutdinova, E.K. (2022) 2, CHEK2 and NBN genes,
potentially pathogenic genetic variants in new breast and ovarian cancer